Camber Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-266,667
Closed -$21.6M 46
2022
Q1
$21.6M Buy
266,667
+16,667
+7% +$1.35M 0.78% 29
2021
Q4
$50.7M Hold
250,000
1.74% 20
2021
Q3
$67.4M Buy
250,000
+16,667
+7% +$4.49M 2.07% 21
2021
Q2
$60.1M Buy
233,333
+100,000
+75% +$25.7M 2.02% 20
2021
Q1
$40M Sell
133,333
-33,334
-20% -$10M 1.37% 23
2020
Q4
$42.5M Hold
166,667
1.49% 19
2020
Q3
$41.5M Sell
166,667
-33,333
-17% -$8.29M 2.19% 16
2020
Q2
$69.5M Hold
200,000
3.98% 9
2020
Q1
$53.6M Sell
200,000
-50,000
-20% -$13.4M 3.2% 15
2019
Q4
$80.9M Buy
250,000
+50,000
+25% +$16.2M 4.12% 11
2019
Q3
$54.6M Buy
200,000
+33,333
+20% +$9.11M 2.87% 15
2019
Q2
$89M Buy
166,667
+33,334
+25% +$17.8M 4.15% 6
2019
Q1
$67.2M Hold
133,333
3.35% 12
2018
Q4
$65.7M Buy
133,333
+33,333
+33% +$16.4M 3.12% 12
2018
Q3
$91.4M Sell
100,000
-33,333
-25% -$30.5M 3.91% 8
2018
Q2
$97.7M Buy
133,333
+33,333
+33% +$24.4M 3.76% 9
2018
Q1
$159M Sell
100,000
-123,333
-55% -$197M 7.83% 2
2017
Q4
$200M Sell
223,333
-123,334
-36% -$110M 9.79% 1
2017
Q3
$125M Sell
346,667
-10,000
-3% -$3.6M 7.91% 1
2017
Q2
$105M Sell
356,667
-3,333
-0.9% -$977K 5.09% 4
2017
Q1
$127M Sell
360,000
-40,000
-10% -$14.1M 5.14% 4
2016
Q4
$73.6M Buy
400,000
+186,667
+88% +$34.4M 3.83% 7
2016
Q3
$55M Sell
213,333
-70,000
-25% -$18M 2.42% 15
2016
Q2
$60.5M Sell
283,333
-16,667
-6% -$3.56M 2.92% 13
2016
Q1
$61.9M Buy
300,000
+66,667
+29% +$13.8M 3.62% 10
2015
Q4
$59M Buy
233,333
+83,333
+56% +$21.1M 3.81% 9
2015
Q3
$24.7M Buy
150,000
+50,000
+50% +$8.22M 2.11% 16
2015
Q2
$18.8M Buy
+100,000
New +$18.8M 1.28% 22